Literature DB >> 15116293

Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

Lennox K Archibald1, Shailen N Banerjee, William R Jarvis.   

Abstract

We reviewed Clostridium difficile-associated disease (CDAD) data from the intensive care unit (ICU) and hospital-wide surveillance components of the National Nosocomial Infections Surveillance System hospitals during 1987-2001. ICU CDAD rates increased significantly only in hospitals with >500 beds (P<.01) and correlated with the duration of ICU stay (r=0.82; P<.05). Hospital-wide (non-ICU) rates increased only in hospitals with <250 beds (P<.01) and in general medicine patients versus surgery patients (P<.0001). CDAD predominated in general hospitals versus other facility types, and rates were significantly higher during winter versus nonwinter months (P<.01). Thus, prevention efforts should be targeted to high-risk groups in these settings.

Entities:  

Mesh:

Year:  2004        PMID: 15116293     DOI: 10.1086/383045

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  65 in total

Review 1.  Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review.

Authors:  Marwan S Abougergi; John H Kwon
Journal:  Dig Dis Sci       Date:  2010-10-06       Impact factor: 3.199

2.  Clostridium difficile infection in hospitals: a brewing storm.

Authors:  Louis Valiquette; Donald E Low; Jacques Pépin; Allison McGeer
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

3.  Clostridium difficile: a formidable foe.

Authors:  Vivian G Loo; Michael D Libman; Mark A Miller; Anne-Marie Bourgault; Charles H Frenette; Mirabelle Kelly; Sophie Michaud; Tuyen Nguyen; Louise Poirier; Anne Vibien; Ruth Horn; Pierre J Laflamme; Pierre René
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

4.  Intravenous immunoglobulin in treatment of Clostridium difficile colitis.

Authors:  Lokesh Shahani; Janak Koirala
Journal:  BMJ Case Rep       Date:  2012-05-08

Review 5.  Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Authors:  Linda D Bobo; Erik R Dubberke
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

6.  Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Authors:  Sahil Khanna; Arjun Gupta; Larry M Baddour; Darrell S Pardi
Journal:  Intern Emerg Med       Date:  2015-12-22       Impact factor: 3.397

7.  Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Andrew E Simor; Alex Kopp; Paula A Rochon; David N Juurlink
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

8.  Prevalence of Clostridium difficile in retail pork.

Authors:  Devon Metcalf; Richard J Reid-Smith; Brent P Avery; J Scott Weese
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

9.  Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.

Authors:  Richard Cunningham
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

10.  Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.

Authors:  L Fenner; R Frei; M Gregory; M Dangel; A Stranden; A F Widmer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.